Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Healthcare Biotechnology
Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Sernova Corp > Survey Says
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(43)
•••
Comment by Metalsguy1on Apr 17, 2022 2:26am
168 Views
Post# 34608121

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Survey Says

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Survey Says
Always keep your hand in Mercaderp? Sounds like your pillow talk with management. I suggest you go back and look at the original timeline for SVA. The difference between SVA and Vertexis that SVA appears to have intentionally misled investors with an 18 month timeline for Phase 1/2. I guess you like rough trade if you are happy with an add on of 3+ years. Any newbies coming to SVA deserve to know the big picture not just your happy $2 hooking version of the company. Why don't I play for a few nickels? Because I have trading plan that I stick to and I have no need or interests in day or swing trading. Why don't you get a real job instead of playing the company shill?
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities